| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,715 |
1,674 |
$161K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
623 |
610 |
$107K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
407 |
407 |
$53K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
352 |
352 |
$49K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,189 |
619 |
$40K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
501 |
492 |
$39K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
285 |
285 |
$33K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,006 |
1,004 |
$31K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
204 |
189 |
$29K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
549 |
549 |
$12K |
| 99051 |
|
483 |
478 |
$11K |
| 90461 |
|
678 |
193 |
$10K |
| 96127 |
|
448 |
447 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
351 |
346 |
$7K |
| 87081 |
|
271 |
268 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
186 |
186 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
25 |
25 |
$1K |
| 83655 |
|
26 |
26 |
$433.94 |
| 85027 |
|
12 |
12 |
$106.92 |